LOI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 2.832
EU - Europa 1.682
AS - Asia 614
AF - Africa 9
OC - Oceania 2
SA - Sud America 1
Totale 5.140
Nazione #
US - Stati Uniti d'America 2.822
RU - Federazione Russa 943
IE - Irlanda 209
IT - Italia 191
HK - Hong Kong 174
CN - Cina 160
SG - Singapore 148
SE - Svezia 131
PL - Polonia 86
JO - Giordania 59
DE - Germania 41
IN - India 41
FI - Finlandia 22
GB - Regno Unito 22
KR - Corea 22
CA - Canada 9
CZ - Repubblica Ceca 9
CI - Costa d'Avorio 8
ES - Italia 7
FR - Francia 6
VN - Vietnam 6
UA - Ucraina 4
BE - Belgio 3
CH - Svizzera 3
AU - Australia 2
GR - Grecia 2
AT - Austria 1
BR - Brasile 1
GL - Groenlandia 1
JP - Giappone 1
LT - Lituania 1
NG - Nigeria 1
NL - Olanda 1
PH - Filippine 1
TH - Thailandia 1
TR - Turchia 1
Totale 5.140
Città #
Santa Clara 588
Fairfield 285
Chandler 248
Dublin 209
Ashburn 202
Seattle 148
Dearborn 141
Woodbridge 141
Cambridge 128
Hong Kong 123
Houston 116
Singapore 113
Wilmington 101
Warsaw 86
Florence 49
Lawrence 47
Altamura 42
Beijing 42
Princeton 40
Ann Arbor 39
Shanghai 37
Moscow 33
Buffalo 31
Mumbai 29
New York 28
San Diego 26
Seoul 22
Boston 19
Medford 19
Munich 16
Kent 15
Los Angeles 15
Helsinki 13
West Jordan 11
Nanjing 10
Yubileyny 9
Abidjan 8
Falls Church 8
Pune 8
Brno 7
London 7
Dong Ket 6
Guangzhou 6
Toronto 6
Barcelona 5
Boardman 5
Hillsboro 5
Norwalk 5
Frankfurt am Main 4
Hefei 4
Kunming 4
Bologna 3
Brussels 3
Garden City 3
Pistoia 3
Rome 3
Bern 2
Busto Arsizio 2
Calgary 2
Cerveteri 2
Chongqing 2
Empoli 2
Falkenstein 2
Fiesole 2
Kilburn 2
Milan 2
Nagold 2
Palombara Sabina 2
Prato 2
Redwood City 2
Romainville 2
Rui'an 2
Scarperia e San Piero 2
Southwark 2
Sydney 2
Thessaloniki 2
Tuen Mun 2
Wandsworth 2
Washington 2
Wuhan 2
Wuxi 2
Xi'an 2
Acton 1
Andover 1
Berlin 1
Bracknell 1
Brentford 1
Brescia 1
Cabanatuan City 1
Castelliri 1
Cedar Knolls 1
Changchun 1
Changsha 1
Chengdu 1
Clifton 1
Colle di Val d'Elsa 1
Delhi 1
Fremont 1
Fuzhou 1
Gate City 1
Totale 3.394
Nome #
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 187
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 152
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 149
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 148
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 147
Influence of age and subtype in outcome of operable liposarcoma 147
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 143
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 141
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 139
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 133
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 130
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 130
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 128
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 127
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 126
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 126
Radiotherapy in the age of cancer immunology: Current concepts and future developments 122
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 120
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 119
Cancer stem cells: biology and potential therapeutic applications 113
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 113
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 112
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 100
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 95
Prognostic impact of nodal relapse in definitive prostate-only irradiation 90
Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors 84
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 82
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 81
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 75
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 70
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 68
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 66
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 66
Artificial Intelligence in radiotherapy: state of the art and future directions 65
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 64
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 63
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 63
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 60
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 59
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 58
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 56
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 56
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 55
Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC: a multicentric series in four centers 55
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 55
Update chemotherapy schedule in the treatment of lung cancer 53
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 53
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 51
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 50
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 48
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 47
Charlson comorbidity index and G8 in older old adult(≥80 years) hepatocellular carcinoma patients treated with stereotactic body radiotherapy 46
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 46
Chest wall resection and reconstruction for lung cancer: Surgical techniques and example of integrated multimodality approach 45
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 45
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 44
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 40
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 38
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 38
Single-fraction radiotherapy (SFRT) for bone metastases: Patient selection and perspectives 27
Totale 5.209
Categoria #
all - tutte 19.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020737 0 0 0 0 134 168 154 94 86 51 40 10
2020/2021312 29 17 14 62 19 15 9 22 33 38 32 22
2021/2022253 5 13 17 26 6 16 9 26 10 9 43 73
2022/2023961 60 175 50 31 85 175 128 74 133 2 29 19
2023/2024584 20 46 63 26 40 84 36 158 8 29 49 25
2024/20251.939 108 320 181 569 761 0 0 0 0 0 0 0
Totale 5.209